Update under Regulation 30 read with Para A Part A of Schedule III of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015
MEDPLUS · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Medplus Health Services' subsidiary, Optival Health Solutions Private Limited, received an order suspending the drug license of one of its stores located on Kalyanadurgham Road in Andhra Pradesh for seven days. The order was issued by the Assistant Director, District Sales Licensing Authority, Drugs Control Administration, Ananthapuramu Zone-I on September 21, 2025, under Rule 65 of the Drugs and Cosmetics Act, 1940. The company has disclosed a potential revenue loss of approximately Rs 1.48 lakhs from this suspension. The order relates to alleged violations under the Drugs and Cosmetics Act and Rules.
The financial impact is negligible at around Rs 1.48 lakhs and limited to a single store for just 7 days, so this is unlikely to materially affect the stock or overall business operations given Medplus's large store network.